echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > eLife: Heart disease causes early brain dysfunction and triples key Alzheimer's protein

    eLife: Heart disease causes early brain dysfunction and triples key Alzheimer's protein

    • Last Update: 2022-01-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The new study, published in the journal eLife, found that heart disease can cause a breakdown in a key brain function that connects brain activity and blood flow, meaning the same activity causes the brain to get less blood


    This occurs before fat builds up in the blood vessels of the brain in people with heart disease (atherosclerosis), a precursor to dementia


    The researchers also found that the combination of heart disease and a genetic predisposition to Alzheimer's disease tripled the amount of beta-amyloid, a protein that forms and triggers Alzheimer's disease, and increased levels of an inflammatory gene (IL1) in the brain


    Lead author of the study, Dr Osman Shabir, from the University of Sheffield's Institute for Neuroscience and Healthy Longevity, said: "Alzheimer's is the most common form of dementia in the world and heart disease is Alzheimer's major risk factors


    "We found that heart disease in midlife causes a breakdown in neurovascular coupling, an important mechanism in our brain that controls the amount of blood supplied to neurons


    The team has since received a three-year grant from the British Heart Foundation to study the use of an arthritis drug targeting IL-1 to see if it can reverse or reduce brain dysfunction caused by heart disease


    The team also found that brain injury also worsened cerebral blood flow regulation, supporting the observation that symptoms tend to worsen after an injury or fall


    Journal Reference :

    1. Osman Shabir, Ben Pendry, Llywelyn Lee, Beth Eyre, Paul S Sharp, Monica A Rebollar, David Drew, Clare Howarth, Paul R Heath, Stephen B Wharton, Sheila E Francis, Jason Berwick.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.